FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $9.22 million versus the consensus estimate of $13.27 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
... More
